Toxoplasmose ocular com reação em cadeia da polimerase positiva em sangue periférico – relato de dois casos, estado de São Paulo, Brasil
DOI:
https://doi.org/10.15448/1980-6108.2015.4.20932Palavras-chave:
Toxoplasma gondii, toxoplasmose, ocular, retinocoroidite, corioretinite, retinografia, tomografia de coerência óptica, PCR, reação em cadeia da polimeraseResumo
Objetivos: Descrever o uso da reação em cadeia da polimerase (PCR) no sangue periférico e demonstrar sua importância no acompanhamento clínico de pacientes com toxoplasmose ocular.
Descrição dos casos: Dois pacientes imunocompetentes foram clinicamente diagnosticados com toxoplasmose ocular aguda. Rotineiramente, a avaliação clínica foi feita por fundoscopia com o uso de oftalmoscópio binocular indireto, retinografia colorida, angiografia fluorescente e tomografia de coerência óptica espectral. A sorologia foi realizada por ELISA (IgM, IgG) e confirmada por ELFA (IgG, IgM). O diagnóstico molecular foi realizado por PCR em sangue periférico usando o gene B1 de Toxoplasma gondii como marcador. O paciente mais jovem era do sexo masculino, apresentava lesão prévia no olho direito, queixa de baixa acuidade visual no olho esquerdo e estava sob tratamento. O paciente mais velho era do sexo masculino, apresentava descolamento de retina e súbita diminuição de visão no olho direito. A fundoscopia revelou cicatriz coriorretiniana no olho esquerdo. Ambos os pacientes tinham IgG reagente, IgM não reagente e PCR positivo em sangue periférico. Novas amostras de sangue foram coletadas para monitoramento sorológico e molecular e a PCR permaneceu positiva em ambos os casos. Seis semanas após o início do tratamento com sulfadiazina e pirimetamina oral, os resultados do PCR tornaram-se negativos.
Conclusões: Os resultados mostram que antígenos de T. gondii podem ser encontrados em sangue periférico durante as reativações oculares e que a PCR parece ser uma boa ferramenta para o acompanhamento de pacientes com toxoplasmose ocular.
Downloads
Referências
Lopes AP, Dubey JP, Dardé M-L, Cardoso L. Epidemiological review of Toxoplasma gondii infection in humans and animals in Portugal. Parasitology. 2014;141(13):1699–708. http://dx.doi.org/10.1017/S0031182014001413
Malik A, Rizvi M, Khan F, Khan N, Rabbani T, Khan HM. Toxoplasma gondii in women with bad obstetric history and infertility: a five-year study. Asian Pac J Trop Dis. 2014;4:S236–9. http://dx.doi.org/10.1016/S2222-1808(14)60446-1
Nascimento LV, Stollar F, Tavares LB, Cavasini CE, Maia IL, Cordeiro JA, Ferreira MU. Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case-control study in Brazil. Ann Trop Med Parasitol. 2001;95(6):587–93. http://dx.doi.org/10.1080/00034980120073931
Silva MMG. Neurologic complications of HIV in the HAART era: where are we? The Braz J Infect Dis. 2012;16(4):373–8. http://dx.doi.org/10.1016/j.bjid.2012.06.021
Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139(11):1375–424. http://dx.doi.org/10.1017/S0031182012000765
Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort Jr R, Vítor RWA, Silveira C, Sibley LD. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis. 2006;12(6):942–9. http://dx.doi.org/10.3201/eid1206.060025
Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277. http://dx.doi.org/10.1371/journal.pntd.0000277
Pfaff AWA, De-la-Torre A, Rochet E, Brunet J, Sabou M, Sauer A, Bourcier T, Gomez-Marin JE, Candolfi E. New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis. Int J Parasitol. 2014;44(2):99–107. http://dx.doi.org/10.1016/j.ijpara.2013.09.007
Maenz M, Schlüter D, Liesenfeld O, Schares G, Gross U, Pleyer U. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. 2014;39:77–106. http://dx.doi.org/10.1016/j.preteyeres.2013.12.005
Jones JL, Parise ME, Fiore AE. Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg. 2014;90(5):794–9. http://dx.doi.org/10.4269/ajtmh.13-0722
Boothroyd JC, Grigg ME. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol. 2002;5(4):438–42. http://dx.doi.org/10.1016/S1369-5274(02)00349-1
Braakenburg AMD, Crespi CM, Holland GN, Wu S, Yu F, Rothova A. Recurrence rates of ocular toxoplasmosis during pregnancy. Am J Ophthalmol. 2014;157(4):767–73.e2. http://dx.doi.org/10.1016/j.ajo.2014.01.004
Furtado JMJ, Winthrop KLK, Butler NJ, Smith JR. Ocular toxoplasmosis I: parasitology, epidemiology and public health. Clin Experiment Ophthalmol. 2013;41(February):82–94. http://dx.doi.org/10.1111/j.1442-9071.2012.02821.x
Arantes TE, Silveira C, Holland GN, Muccioli C, Yu F, Jones JL, Goldhardt R, Lewis KG, Belfort R Jr. Ocular Involvement Following Post-natally Acquired Toxoplasma gondii Infection in Southern Brazil: A 28-Year Experience. Am J Ophthalmol. 2015. http://dx.doi.org/10.1016/j.ajo.2015.02.015
Ferreira AIC, De Mattos CCB, Frederico FB,Meira CS, Almeida GC Jr, Nakashima F, Bernardo CR, Pereira-Chioccola VL, De Mattos LC. Risk factors for ocular toxoplasmosis in Brazil. Epidemiol Infec. 2014;142(1):142–8. http://dx.doi.org/10.1017/S0950268813000526.
Rodrigues A, Uezato S, Vono M, Pandossio T; Spegiorin LCJF; Oliani AH; Vaz Oliani DCM; Brandão de Mattos CC; de Mattos LC. Non-association between anti-Toxoplasma gondii antibodies and ABO blood group system. J Venom Anim Toxins incl Trop Dis. 2011;17(2):184–9. http://dx.doi.org/10.1590/S1678-91992011000200009
Gonçalves MAS, Mattos CCB, Spegiorin LCJF, Oliani DCMV, Oliani AH, de Mattos LC. Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo state, Brazil. Braz J Infect Dis. 2010;14(6):601–5. http://dx.doi.org/10.1016/S1413-8670(10)70118-5
Mattos CCB, Cintra JR, Ferreira AIC, Spegiorin LCJF, Galisteu KJ, Machado RLD, de Mattos LC. Lack of association between ABO histo-blood groups, secretor and non-secretor phenotypes, and anti-Toxoplasma gondii antibodies among pregnant women from the northwestern region of Sao Paulo State, Brazil. Arch Med Sci. 2008;4(3):254–8.
Mendes NHD, Oliveira CBS, Garcia CA, Holanda CMXC, Andrade-Neto VF. Epidemiological and serological profiles of ocular toxoplasmosis in the municipality of Natal, northeastern Brazil. Trans R Soc Trop Med Hyg. 2014;108(10):656–61. http://dx.doi.org/10.1093/trstmh/tru113
Dantas SSBA, Fernandes ARF, Souza Neto OL, Mota RA, Alves CJ, Azevedo SS. Occurrence and risk factors associated with Toxoplasma gondii and Neospora caninum infections in dogs in the county of Natal, Rio Grande do Norte state, Northeastern Brazil. Ciência Rural. 2013;43(11):2042–8. http://dx.doi.org/10.1590/S0103-84782013001100020
Silva LLA, Andrade RRO, Carneiro ACA V, Vitor RRWA. Overlapping Toxoplasma gondii Genotypes Circulating in Domestic Animals and Humans in Southeastern Brazil. PloS One. 2014;9(2):e90237. http://dx.doi.org/10.1371/journal.pone.0090237
Costa JG, Carneiro AC, Tavares AT, Andrade GM, Vasconcelos-Santos DV, Januário JN, Menezes-Souza D, Fujiwara RT, Vitor RW. Real-time PCR as a prognostic tool for human congenital toxoplasmosis. J Clin Microbiol. 2013;51(8):2766–8. http://dx.doi.org/10.1128/JCM.00982-13
Previato M, Frederico FB, Murata FH, Siqueira RC, Barbosa AP, Silveira-Carvalho AP, Meira CS, Pereira-Chioccola VL, Gava R, Martins Neto PP, de Mattos LC, Brandão de Mattos CC. A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis. BMC Res Notes. 2015; 8:746. http://dx.doi.org/10.1186/s13104-015-1650-6
Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L'ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicentre retrospective study. J Clin Microbiol. 2013;51(7):2103–11. http://dx.doi.org/10.1128/JCM.00169-13
Mattos CCB, Meira CS, Ferreira AIC, Frederico FB, Hiramoto RM, Jr GC, Mattos LC, Pereira-Chioccola VL. Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients. Diagn Microbiol Infect Dis. 2011;70(3):362–6. http://dx.doi.org/10.1016/j.diagmicrobio.2011.02.002
Novais EA, Commodaro AG, Santos F, Muccioli C, Maia A, Nascimento H, Moeller CT, Rizzo LV, Grigg ME, Belfort R Jr. Patients with diffuse uveitis and inactive toxoplasmic retinitis lesions test PCR positive for Toxoplasma gondii in their vitreous and blood. Br J Ophthalmol. 2014;98(7):937–40. http://dx.doi.org/10.1136/bjophthalmol-2013-304184
Oréfice JL, Costa RA, Scott IU, Calucci D, Oréfice F. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1). Acta Ophthalmol. 2013;91(1):e41–7. http://dx.doi.org/10.1111/j.1755-3768.2012.02531.x
Villard O, Cimon B, L'Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. Serological Diagnosis of Toxoplasma gondii Infection: Recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis. 2015;84(1):22–33. http://dx.doi.org/10.1016/j.diagmicrobio.2015.09.009
Blanco PJ, Assia YM, Montero YM, Orozco KE. ELFA IgG anti-Toxoplasma y PCR anidada para el diagnóstico de toxoplasmosis en mujeres gestantes de Sincelejo, Colombia. Infectio. 2011;15(4):253–8. http://dx.doi.org/10.1016/S0123-9392(11)70739-1
Silveira C, Vallochi AL, Rodrigues da Silva U, Muccioli C, Holland GN, Nussenblatt RB, Belfort R, Rizzo LV. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol. 2011;95(3):396–400. http://dx.doi.org/10.1136/bjo.2008.148205
Gómez-Marín JEJ, de-la-Torre A, Barrios P, Cardona N, Álvarez C, Herrera C. Toxoplasmosis in military personnel involved in jungle operations. Acta Trop. 2012;122(1):46–51. http://dx.doi.org/10.1016/j.actatropica.2011.11.019
Andújar BR, Pe-a MSR, Nodarse JF, Rivero LR, Fernandéz FAN, Puebla LEJ. Aplicación de herramientas serológicas y moleculares para el diagnóstico de coriorretinitis por Toxoplasma gondii. Rev Cubana Med Trop. 2013;65(1):13–25.
Sull AC, Vuong LN, Price LL, Srinivasan VJ, Gorczynska I, Fujimoto JG, Schuman JS, Duker JS. Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina. 2010;30(2):235–45. http://dx.doi.org/10.1097/IAE.0b013e3181bd2c3b
Belaz S, Gangneux J-P, Dupretz P, Guiguen C, Robert-Gangneux F. A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR. J Clin Microbiol. 2015;53(4):JCM.02900–14. http://dx.doi.org/10.1128/JCM.02900-14
Olariu TR, Remington JS, Montoya JG. Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J. 2014;33(6):566–70. http://dx.doi.org/10.1097/INF.0000000000000256
Barbosa MA, Angelin LG, Saikawa GIA, Oliveira CJS, Silva SS, Vendruscolo JW, Marinello PC, Fujita TC, Rocha SPD, Watanabe MAE, Mitsuka-Bregano R, Costa IN. Potenciais alternativas terapêuticas em estudo para a toxoplasmose congênita: uma revisão bibliográfica. Rev Patol Trop. 2015:44:1–11. http://dx.doi.org/10.5216/rpt.v44i1.34798
Mancini DT, Assis LC, Ramalho TC, Cunha EF, Franca TCC. Toxoplasmose: Perspectivas no Estudo de Novos Alvos Terapêuticos. Rev Virt Quím. 2012;4(4):434–55.
Paquet C, Yudin MH. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2013;35(1):78–81. http://dx.doi.org/10.1016/S1701-2163(15)31053-7
Nakao M, Yamamoto I, Yamamoto H. Successful treatment of ocular toxoplasmosis that developed four years after kidney transplantation. Transpl Int.2015;28(3):363-5. http://dx.doi.org/10.1111/tri.12433
Schallhorn JM, Gonzales J. Ocular toxoplasmosis: the treatment dilemma. J AAPOS. 2013;17(5):454–5. http://dx.doi.org/10.1016/j.jaapos.2013.08.001
Kijlstra A, Petersen E. Epidemiology, pathophysiology, and the future of ocular toxoplasmosis. Ocul Immunol Inflamm. 2014;22(2):138–47. http://dx.doi.org/10.3109/09273948.2013.823214
Pleyer U, Alió JL, Barisani-Asenbauer T, Le Hoang P, Rao NA. Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. http://dx.doi.org/10.1007/978-3-642-54350-0
Jensen KD, Camejo A, Melo MB, Cordeiro C, Julien L, Grotenbreg GM, Frickel EM, Ploegh HL, Young L, Saeij JP. Toxoplasma gondii Superinfection and Virulence during Secondary Infection Correlate with the Exact ROP5/ROP18 Allelic Combination. mBio. 2015;6(2):e02280-14. http://dx.doi.org/10.1128/mBio.02280-14
Avelino MM, Amaral WN, Rodrigues IM, Rassi AR, Gomes MB, Costa TL, Castro AM. Congenital toxoplasmosis and prenatal care state programs. BMC Infect Dis. 2014;14(1):33. http://dx.doi.org/10.1186/1471-2334-14-33
Grigg ME, Dubey JP, Nussenblatt RB. Ocular toxoplasmosis: lessons from Brazil. Am J Ophthalmol. 2015;159(6):999–1001. http://dx.doi.org/10.1016/j.ajo.2015.04.005
